Author: Jack H. Gardner
The number and scope of drug discovery outsourcing
agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are
aggressively pursuing a range of outsourcing agreements. On the supplier side, smaller vendors rely on outsourcing revenues to pay their bills and boost their credibility. Outsourcing in drug discovery is a popular topic for trade articles and seminars. These generally focus on who is doing what with whom for how much. This report will not cover this familiar territory. Instead it will provide a
strategic view by showing what motivates clients and…
